Safety and Efficacy of Oshadi D and Oshadi R for Malignant Mesothelioma Treatment
Clinical trial NCT01627795 · SUSPENDED
Trial details
- NCT number
- NCT01627795
- Sponsor
- Oshadi Drug Administration
- Status
- SUSPENDED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-12-01
- Primary completion
- 2018-08-01
- Enrollment
- 17
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.